Format

Send to

Choose Destination
See comment in PubMed Commons below
IDrugs. 2010 Jun;13(6):369-71.

Natural peptides to drugs - fourth international congress.

Author information

  • 1MannKind Corp, 1 Casper Street, Danbury, CT 06810, USA. aleone-bay@mannkindcorp.com

Abstract

The Natural Peptides to Drugs congress, held in Zermatt, Switzerland, included topics covering new therapeutic developments in the field of peptide- and protein-based drugs derived from natural products. This conference report highlights selected presentations on drug discovery from natural peptides, natural peptide-based drugs in preclinical and clinical development, and peptide candidates. Investigational drugs discussed include novel small peptides from KAI Pharmaceuticals Inc, XEP-018 (Atheris Laboratories), MKC-253 (MannKind Corp), AEZS-108 (AEterna Zentaris Inc) and XG-102 (Auris Medical AG/Xigen SA).

PMID:
20506056
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center